DEA Continues Bid to Make Any Extract of the Cannabis Plant a Schedule 1 Drug

On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which could ultimately impact the development of drug treatments related to cannabinoids that are used to treat the symptoms of concussion. Robert Hoban, a cannabis, cannabinoid and hemp lawyer and expert as well as an adjunct professor…
Read more